Emerging Trends to Reshape the Global Cell Expansion Market: Technological Advancements Fuel Innovation In Cell Expansion Market as a Key Influencer

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cell Expansion Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing cell expansion has experienced swift upward movement recently, projected to increase from a valuation of $28.11 billion in the year 2024 to $32.31 billion the following year, reflecting a 15.0% compound annual growth rate (CAGR); this expansion during the past period stems from factors such as increased public consciousness and endorsement, the proliferation of cell-based research uses, escalating requirements for cell-based treatments, the burgeoning biopharmaceutical sector, and progress in the realm of regenerative medicine.

Cell Expansion Market Size Forecast: What's the Projected Valuation by 2029?
The cell expansion market is projected to witness significant growth in the coming years, reaching $59.31 billion by 2029 at a compound annual growth rate (CAGR) of 16.4%. The anticipated growth during the forecast period can be attributed to increased investments in biotechnology, the expansion of stem cell research, advancements in clinical trials and drug development, the rising demand for personalized medicine, and the growth of biobanking and cell repositories. Key trends expected in this period include technological advancements, innovative product developments, and strategic collaborations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

What Are the Drivers Transforming the Cell Expansion Market?
Anticipation suggests that a rising tide of long-term health conditions, defined as persistent ailments that, while sometimes manageable or curable, often cannot be fully resolved, will fuel the need for cell expansion solutions. This escalation in chronic illnesses can be attributed to numerous lifestyle factors, including elevated tobacco consumption, inadequate dietary habits, sedentary behavior, and unrestrained alcohol intake, among others. The process of cell expansion plays a crucial role by facilitating the necessary nutrient supply while simultaneously mitigating the buildup of harmful metabolic byproducts that could otherwise compromise the efficiency of the culture. To illustrate this trend, data from the National Center for Biotechnology Information (NCBI), a branch of the US National Library of Medicine, indicated in January 2023 that the count of persons aged fifty and older afflicted with at least a single chronic condition is forecast to nearly double by 2050, jumping from 71.522 million in 2020 to reach 142.66 million, thereby making the escalation in chronic disease prevalence a key catalyst for the expansion of the cell expansion market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

What Long-Term Trends Will Define the Future of the Cell Expansion Market?
Key players within the cell expansion sector are heavily concentrating on progress within bioprocessing methods, exemplified by sophisticated automated three-dimensional bioreactor setups, aiming to boost both the effectiveness and the capacity for producing cells destined for medical treatments. PluriCDMO facilitates the large-scale, automated fabrication of cell therapies, relying on its unique 3D bioreactor platform to guarantee consistent, premium output spanning from initial research phases right up to clinical evaluation stages. Separately, in a development from January 2024, Pluristem Therapeutics Inc., an Israeli biotech firm, inaugurated a distinct business unit called PluriCDMO, established to deliver cell therapy manufacturing capabilities as a contract development and manufacturing organization (CDMO). This recently established division incorporates a substantial 47,000-square-foot facility engineered for good manufacturing practice (GMP) level cell therapy production. Substantially, this new entity will enable Pluri to extend its service offerings covering the entire spectrum from initial preclinical research efforts through to subsequent clinical phases and ultimate market launch.

Which Segments in the Cell Expansion Market Offer the Most Profit Potential?
The cell expansionmarket covered in this report is segmented -

1) By Cell Type: Mammalian; Microbial; Other Cell Types
2) By Product: Consumables; Reagents; Media; Serum; Disposables; Instruments
3) By Application: Biopharmaceuticals; Tissue Culture And Engineering; Vaccine Production; Drug Development; Gene Therapy; Cancer Research; Stem Cell Research; Other Applications
4) By End-user: Biopharmaceutical And Biotechnology Companies; Research Institutes; Cell Banks; Other End-Users

Subsegments:
1) By Mammalian: Adherent Cells; Suspension Cells; Stem Cells
2) By Microbial: Bacterial Cells; Yeast Cells; Fungal Cells
3) By Other Cell Types: Plant Cells; Insect Cells; Hybridoma Cells

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8264&type=smp

Which Firms Dominate the Cell Expansion Market by Market Share and Revenue in 2025?
Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton dic*kinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd., Worthington Industries Inc.

Which Regions Offer the Highest Growth Potential in the Cell Expansion Market?
North America was the largest region in the cell expansion market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8264

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.